The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants.

[1]  L. Scapozza,et al.  Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue , 2020, International journal of pharmaceutics: X.

[2]  K. Kogure,et al.  Non-invasive delivery of biological macromolecular drugs into the skin by iontophoresis and its application to psoriasis treatment. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Y. Kalia,et al.  Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation. , 2020, International journal of pharmaceutics.

[4]  Y. Kalia,et al.  Non-invasive targeted iontophoretic delivery of cetuximab to skin , 2020, Expert opinion on drug delivery.

[5]  Y. Kalia,et al.  Controlled iontophoretic delivery in vitro and in vivo of ARN14140 - a multi-target compound for Alzheimer's disease. , 2019, Molecular pharmaceutics.

[6]  Emily Wenande,et al.  Fundamentals of fractional laser-assisted drug delivery: An in-depth guide to experimental methodology and data interpretation. , 2019, Advanced drug delivery reviews.

[7]  Y. Kalia,et al.  Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  Y. Kalia,et al.  Formulation challenges for 21st century topical and transdermal delivery systems , 2017, Expert opinion on drug delivery.

[9]  Y. Kalia,et al.  Cutaneous iontophoresis of μ-conotoxin CnIIIC-A potent NaV1.4 antagonist with analgesic, anaesthetic and myorelaxant properties. , 2017, International journal of pharmaceutics.

[10]  K. Sugibayashi,et al.  Effect of Combination of Low-Frequency Sonophoresis or Electroporation with Iontophoresis on the Mannitol Flux or Electroosmosis through Excised Skin. , 2016, Biological & pharmaceutical bulletin.

[11]  J. Hirvonen,et al.  Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber. , 2014, European journal of pharmaceutics and biopharmaceutics.

[12]  Y. Kalia,et al.  Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  H. Moghimi,et al.  Iontophoretic skin permeation of peptides: an investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters , 2014, Drug Delivery and Translational Research.

[14]  I. Alberti,et al.  Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  M. Prausnitz,et al.  Skin pretreatment with microneedles prior to pilocarpine iontophoresis increases sweat production , 2013, Clinical physiology and functional imaging.

[16]  Y. Kalia,et al.  Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  Y. Kalia,et al.  Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier. , 2013, Advanced drug delivery reviews.

[18]  Y. Kalia,et al.  Non-invasive iontophoretic delivery of peptides and proteins across the skin , 2011, Expert opinion on drug delivery.

[19]  Y. Kalia,et al.  Effect of controlled laser microporation on drug transport kinetics into and across the skin. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Y. Kalia,et al.  Development and validation of an analytical method for the quantification of cytochrome c in skin transport studies. , 2009, Biomedical chromatography : BMC.

[21]  A. Banga,et al.  Transdermal delivery of a ~13 kDa protein—an in vivo comparison of physical enhancement methods , 2009, Journal of drug targeting.

[22]  Tielin Shi,et al.  Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[23]  A. Banga,et al.  Molecular charge mediated transport of a 13 kD protein across microporated skin. , 2009, International journal of pharmaceutics.

[24]  G. M. Gelfuso,et al.  The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4). , 2008, Journal of pharmaceutical sciences.

[25]  Y. Kalia,et al.  Transdermal Delivery of Cytochrome C—A 12.4 kDa Protein—Across Intact Skin by Constant–Current Iontophoresis , 2007, Pharmaceutical Research.

[26]  K. Sugibayashi,et al.  Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Y. Kalia,et al.  Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Aarti Naik,et al.  Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.

[29]  R H Guy,et al.  Characterization of the iontophoretic permselectivity properties of human and pig skin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.